- Home
- Mushroom Extracts
- Chaga Mushroom Extract
Chaga Mushroom Extract (Inonotus obliquus) – Total Polysaccharides 10–50%
Inonotus obliquus
- Marker compound
- Total polysaccharides
- Standardisation
- 10–50% (UV-Vis spectrophotometry)
- Assay method
- UV-Vis spectrophotometry
- Plant part
- Fruiting Body (mushroom)
- Origin
- Russia, Finland, Canada
Chaga Mushroom Extract (Inonotus obliquus) – Total Polysaccharides 10–50%
Chaga extract is produced from the sclerotium of Inonotus obliquus (Hymenochaetaceae family) and supplied as a standardized mushroom extract, standardized to Total polysaccharides. Available grades: 10%, 30%, 50%. Typical sourcing: Russia, Finland, Canada. For B2B formulation in nutraceuticals & supplements.
10%30%50%
Specifications
| Botanical name | Inonotus obliquus |
| Common names | Chaga |
| Plant family / part | Hymenochaetaceae / Sclerotium |
| Marker compound | Total polysaccharides |
| Phytochemical class | Polysaccharides › Bioactive polysaccharides & β-glucans |
| Available grades | 10%, 30%, 50% |
| Assay method | UV-Vis spectrophotometry |
| Form | Mushroom Extract |
| Origin | Russia, Finland, Canada |
| Pack sizes | Sample (50 g), 250 g, 1 Kg, 5 Kg, 25 Kg |
| Shelf life & storage | Typically 24 months in sealed original packaging; store cool, dry and away from light |
Formulation focus
- Immune Support
- Antioxidant & Healthy Ageing
Industries
Nutraceuticals & Supplements
Traditional systems: Medicinal mushrooms
Documentation
The Technical Data Sheet and Safety Data Sheet (GHS format) can be downloaded from this page; the batch Certificate of Analysis is supplied on request. Confirm the assay method (HPLC, UV or gravimetric) on the CoA, as results differ between methods.
For B2B formulation and research use. Statements have not been evaluated by the FDA or other regulators; this ingredient is not intended to diagnose, treat, cure or prevent any disease.
Same product form